Literature DB >> 28986899

Circulating Tumor Cells.

Sebastián A García1, Jürgen Weitz2,3,4, Sebastian Schölch2,3,4.   

Abstract

In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors. Among many other capabilities such as migration or immune escape, CTCs require tumor-forming capacities and can therefore be considered stem cell-like cells. This chapter describes the enrichment and isolation of live CTCs from clinical blood samples for molecular characterization and other downstream applications.

Entities:  

Keywords:  Circulating tumor cells; Distant metastases; EpCAM

Mesh:

Substances:

Year:  2018        PMID: 28986899     DOI: 10.1007/978-1-4939-7401-6_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies.

Authors:  Mateusz Kciuk; Adrianna Gielecińska; Somdutt Mujwar; Mariusz Mojzych; Beata Marciniak; Rafał Drozda; Renata Kontek
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.

Authors:  Shichao Zhou; Lili Wang; Wenying Zhang; Feng Liu; Yanjie Zhang; Bin Jiang; JiongYi Wang; Haihua Yuan
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 3.  Metastasis and MAPK Pathways.

Authors:  Mateusz Kciuk; Adrianna Gielecińska; Adrianna Budzinska; Mariusz Mojzych; Renata Kontek
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

Review 4.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Authors:  Suwen Bai; Zunyun Wang; Minghua Wang; Junai Li; Yuan Wei; Ruihuan Xu; Juan Du
Journal:  Front Cell Dev Biol       Date:  2022-03-02

Review 5.  The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review.

Authors:  Qiang Cai; Guoqing Liu; Linsheng Huang; Yuting Guan; Huixia Wei; Zhiqian Dou; Dexi Liu; Yang Hu; Meiling Gao
Journal:  Drug Des Devel Ther       Date:  2022-07-06       Impact factor: 4.319

6.  The prognostic roles of circulating ALDH1+ tumor cell in the patients with non-small cell lung cancer.

Authors:  Shuang Tian; Ya-Nan Xing; Pu Xia
Journal:  Biosci Rep       Date:  2018-10-31       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.